• The Vercise Genus DBS system small, thin and equipped with Bluetooth connectivity to provide enhanced communi- cation and ease of use
• With the VerciseCartesia Directional lead, you can precisely stimulate and refine directional stimulation in both monopolar and bipolar settings
• With Cartesia 3D, precisely shape and steer stimulation where it’s needed most and leverage more programming flexibility to help manage a patient’s ever evolving needs

Benefits

• With MICC we can adjust the amount of current sent to each level and control the shape of the electrical field
• Directional lead allow to steer the current precisely to the area of the brain we want and maximize the stimulation options in order to manage side effects
• Rechargeable battery offers a 25-year lifespan ​
  to lessen the risk of repeat surgeries​
• Wireless Charging System and Wireless Remote  control for intuitive controls and a broad telemetry range simplify the patient experience

Technical parameters

• System Type : MICC
• Amplitude : 0-20 mA
  • Low pulse width : 20-450 µs
• Rate : 2-255 Hz
• Number of contacts: 16
• Type of stimulation :constant current
• Program storage: up to 4 programs
• Rechargeable batterie with zero volt technology
• MRI compatible 1,5 T
• Wireless Recharging : yes
• Wireless Remote : yes
• Remote Range :3m
• Compatible with Medtronic and Abbott

Studies, conclusions and links
https://www.bostonscientific.com/en-EU/products/deep-brain-stimulation-systems/vercise-genus-dbs-system/clinical.html

• 34% improvement in quality of life
• Multiple Independent Current Control (MICC) and directionality Yielded Optimal Stimulation Settings in 92% of Patients
• Vercise DBS offers unique anodic stimulation capabilities that are demonstrated to improve efficacy and side effect threshold
• 65% larger therapeutic window enabled with low pulse width settings combined with Cartesia 3D
• 68% of patient see an improvement in symptoms or reduction in side effects by converting to a Boston Scientific device